This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sullivan, K. E.
Right arrow Articles by Zackai, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sullivan, K. E.
Right arrow Articles by Zackai, E. H.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, September 2002, p. 1129-1131, Vol. 9, No. 5
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.5.1129-1131.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

CD4+ CD25+ T-Cell Production in Healthy Humans and in Patients with Thymic Hypoplasia

Kathleen E. Sullivan,1* Donna McDonald-McGinn,2 and Elaine H. Zackai2

Division of Immunologic and Infectious Diseases,1 Division of Clinical Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 191042

Received 8 March 2002/ Returned for modification 23 May 2002/ Accepted 7 June 2002

Regulatory T cells are found primarily in the CD4+ CD25+ fraction of T cells and play an important role in the prevention of autoimmunity. We examined CD4+ CD25+ T cells in 33 healthy children and adults and compared them to a population with an inherited form of thymic hypoplasia and a predisposition to autoimmune disease. Absolute numbers of CD4+ CD25+ T cells were markedly higher in healthy infants than in infants with chromosome 22q11.2 deletion syndrome.


* Corresponding author. Mailing address: Division of Immunologic and Infectious Diseases, Children's Hospital of Philadelphia, 34th St. and Civic Ctr. Blvd., Philadelphia, PA 19104. Phone: (215) 590-1697. Fax: (215) 590-3044. E-mail: sullivak{at}mail.med.upenn.edu.


Clinical and Diagnostic Laboratory Immunology, September 2002, p. 1129-1131, Vol. 9, No. 5
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.5.1129-1131.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Bluestone, J. A., Tang, Q. (2004). Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc. Natl. Acad. Sci. USA 101: 14622-14626 [Abstract] [Full Text]  
  • Kasow, K. A., Chen, X., Knowles, J., Wichlan, D., Handgretinger, R., Riberdy, J. M. (2004). Human CD4+CD25+ Regulatory T Cells Share Equally Complex and Comparable Repertoires with CD4+CD25- Counterparts. J. Immunol. 172: 6123-6128 [Abstract] [Full Text]